Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells

被引:526
作者
Heller, F
Fuss, IJ
Nieuwenhuis, EE
Blumberg, RS
Strober, W
机构
[1] NIAID, Mucosal Immun Sect, Clin Invest Lab, NIH, Bethesda, MD 20892 USA
[2] Harvard Univ, Sch Med, Div Gastroenterol, Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Royal Netherland Acad Arts & Sci, Ter Meulen Fund, Amsterdam, Netherlands
关键词
D O I
10.1016/S1074-7613(02)00453-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Oxazolone colitis (OC) is an experimental colitis that has a histologic resemblance to human ulcerative colitis. Here we show that IL-13 production is a significant pathologic factor in OC since its neutralization by IL-13Ralpha2-Fc administration prevents colitis. We further show that OC is mediated by NK-T cells since it can be induced neither in mice depleted of NK-T cells nor in mice that cannot present antigen to NK-T cells and mice lacking an NK-T cell-associated TCR. Finally, we show that NK-T cells are the source of the IL-13, since they produce IL-13 upon stimulation by a-galactosylceramide, an NK-T cell-specific antigen. These data thus describe a cellular mechanism underlying an experimental colitis that may explain the pathogenesis of ulcerative colitis.
引用
收藏
页码:629 / 638
页数:10
相关论文
共 50 条
  • [1] ISOLATION AND CHARACTERIZATION OF A CDNA AND GENE CODING FOR A 4TH CD1 MOLECULE
    BALK, SP
    BLEICHER, PA
    TERHORST, C
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (01) : 252 - 256
  • [2] POSITIVE SELECTION OF MOUSE NK1(+) T-CELLS BY CD1-EXPRESSING CORTICAL THYMOCYTES
    BENDELAC, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06) : 2091 - 2096
  • [3] EXPRESSION OF MURINE CD1 ON GASTROINTESTINAL EPITHELIUM
    BLEICHER, PA
    BALK, SP
    HAGEN, SJ
    BLUMBERG, RS
    FLOTTE, TJ
    TERHORST, C
    [J]. SCIENCE, 1990, 250 (4981) : 679 - 682
  • [4] BLUMBERG RS, 1991, J IMMUNOL, V147, P2518
  • [5] Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4
    Boirivant, M
    Fuss, IJ
    Chu, A
    Strober, W
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (10) : 1929 - 1939
  • [6] BROWN AJ, 1997, CHARACTERIZATION POR, V4, P1
  • [7] Interleukins 4 and 13 increase intestinal epithelial permeability by a phosphatidylinositol 3-kinase pathway - Lack of evidence for STAT 6 involvement
    Ceponis, PJM
    Botelho, F
    Richards, CD
    McKay, DM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (37) : 29132 - 29137
  • [8] Chen HJ, 1997, J IMMUNOL, V159, P2240
  • [9] Requirement for V(alpha)14 NKT cells in IL-12-mediated rejection of tumors
    Cui, JQ
    Shin, T
    Kawano, T
    Sato, H
    Kondo, E
    Toura, I
    Kaneko, Y
    Koseki, H
    Kanno, M
    Taniguchi, M
    [J]. SCIENCE, 1997, 278 (5343) : 1623 - 1626
  • [10] Donaldson DD, 1998, J IMMUNOL, V161, P2317